GLUE Monte Rosa Therapeutics, Inc.
Price Chart
Executive Summary
Three top executives at Monte Rosa Therapeutics (CEO, CSO, COO) sold a combined $260K in open-market sales over a 7-day window, with the CEO's sale occurring most recently. The total dollar value is only ~0.015% of the $1.7B market cap, making this a trivial cluster by proportionality standards. The sales coincide with option exercises, suggesting liquidity-driven diversification rather than a coordinated bearish signal.
Key Financial Metrics
Actionable Insight
This cluster is routine and non-informative. The sales are small in dollar terms, tied to option exercises, and likely driven by vesting schedules and tax obligations. No bearish read-through is warranted. Monitor for any material news (pipeline updates, partnership announcements) that could move the stock, but this insider activity alone does not signal a change in outlook.
Key Facts
- CEO Markus Warmuth sold 4,998 shares at $19.41 for $97K on June 1, 2026
- CSO Sharon Townson sold 6,000 shares at $19.87 for $119K on May 29, 2026, after exercising options at $6.14/share
- COO Jennifer Champoux sold 2,175 shares at $20.00 for $44K on May 27, 2026, after exercising options at $3.98/share
- Total cluster value of $260K represents ~0.015% of Monte Rosa's $1.7B market cap
- All three sales are accompanied by option exercises (non-cash or cash exercises), consistent with routine vesting and tax planning
Financial Impact
Total insider sales of $260K, or ~0.015% of market cap — immaterial relative to company size
Risk Factors
- CEO's sale on June 1 is the most recent and could be misinterpreted by the market as a negative signal
- Biotech sector volatility could amplify any perceived insider selling, even if immaterial
Market Snapshot
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-GLUE-1780430795741 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 2, 2026
10d ago
|
Insider Cluster
| $17.59 $17.36 | ▼ −1.31% | ▼ −1.71% | $18.24 (+3.67%) |
|
Jun 2, 2026
10d ago
|
Press Release
| $17.59 $17.36 | ▼ −1.31% | ▼ −1.71% | $18.24 (+3.67%) |
|
Jun 1, 2026
11d ago
|
Insider Cluster
| $17.74 $17.59 | ▼ −0.85% | ▼ −0.15% | $18.24 (+2.79%) |
|
May 7, 2026
5w ago
|
8-K
| $19.81 $19.39 | ▼ −2.12% | ▼ −2.95% | $18.24 (−7.95%) |
|
Apr 20, 2026
7w ago
|
Press Release
| $19.81 $20.89 | ▲ +5.45% | ▲ +6.11% | $18.24 (−7.95%) |
|
Apr 9, 2026
9w ago
|
Insider Cluster
| $18.05 $17.48 | ▼ −3.16% | ▼ −3.10% | $18.24 (+1.02%) |
|
Mar 17, 2026
12w ago
|
Press Release
| $16.03 $15.76 | ▼ −1.68% | ▼ −0.29% | $18.24 (+13.76%) |
|
Mar 16, 2026
12w ago
|
Press Release
| $16.35 $16.03 | ▼ −1.96% | ▼ −2.23% | $18.24 (+11.53%) |
|
Mar 2, 2026
14w ago
|
Insider Cluster
| $18.50 $17.96 | ▼ −2.92% | ▼ −2.00% | $18.24 (−1.43%) |
|
Feb 28, 2026
14w ago
|
Institutional Cluster
| $18.50 $17.96 | ▼ −2.92% | ▼ −2.00% | $18.24 (−1.43%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access